Genexine Inc (095700) — Capital Reinvestment Ratio
Latest as of March 2025:
4.87x
Genexine Inc (095700) has a Capital Reinvestment Ratio of 4.87x as of March 2025, meaning it reinvests 5% of its operating cash flow (₩799.82 Million) in capital expenditures (₩3.89 Billion). See 095700 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.87x
Capex / Operating Cash Flow
Operating Cash Flow
₩799.82 Million
KRW
Capital Expenditures
₩3.89 Billion
KRW
Data as of
Mar 2025
Most recent filing
Genexine Inc Capital Reinvestment Ratio (2009–2012)
This chart tracks Genexine Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Genexine Inc (2009–2012)
Year-by-year Capital Reinvestment Ratio for Genexine Inc from 2009 to 2012. For live market cap and broader valuation context, see 095700 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2012 | 1.45x | ₩1.67 Billion | ₩2.42 Billion | ▼ -95.0% |
| 2009 | 29.24x | ₩35.23 Million | ₩1.03 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow